Unless you are Danish, the likelihood of you getting treatment abroad under the EU cross border healthcare directive appears to be vanishingly small. We fillet a recent report and talk to expert academic Magda Rosenmuller.
London-listed UAE hospital chain NMC Health is to invest $325m into Qatar and Saudi Arabia in the next two years. Although the group acquired Spanish fertility clinic Eugin in February 2015, this announcement indicates NMC sees growth closer to home. Competitors Aster DM and Al Noor also have big plans.
This week we conclude our investigation of the Thai healthcare industry. Without doubt, a fascinating market with huge growth potential, that is now spilling over into the greater ASEAN region. One feature that is unique to the country is the sheer quantity of listed hospital groups – 13 at our latest count. And amongst the […]
Specialist prostate cancer centre, Martini-Klinik, has used patient reported outcome measures (PROMs) to become the largest of its kind in the world. Over 2,200 surgeries are performed annually at the not for profit facility that is linked to a Hamburg university hospital. The model can, and should, become widespread according to CEO, Dr. Detlef Loppow.
Bulgaria is the poorest and most corrupt country in the European Union. It also has a surprisingly large private hospital sector. As in Turkey and Finland, patients are free to use their National Health Insurance Funds to partly pay for private treatment. The public sector appears to be in terminal retreat. Here we profile the top ten players and talk to several CEOs on why and where they see expansion.
It will come as no surprise that Greece’s healthcare system is under pressure, one that will worsen under new austerity measures. We take a look at what is happening and at a potential saving grace for operators.
The legacy of a British healthcare system, but without the infrastructure; that was the key issue highlighted by Myanmar’s deputy minister of health, Dr Thein Thein Htay in Bali last week at the Southeast Asia Healthcare Summit. Myanmar is now in phase 1 of implementing universal healthcare for its 50 million population by 2030, but the road is long, winding and heavily reliant on donor support.
Approximately 15% of the population already use private healthcare in Thailand and domestic hospital groups are enjoying a universal healthcare coverage inspired renaissance. What are the main drivers? Where is the market going? And will foreign groups be enticed in by these rich pickings? John Low gives his insights.
Nestled between the giant Indian, Chinese and Malaysian markets, Thailand has long passed under the radar. No more. Public health reform and aging populations have spurred rapid growth. And no longer content with medical tourists, its highly profitable hospital groups are moving abroad. Can these dark horses take advantage of the integration of ASEAN and become the dominant force in the region?
Bumrungrad is a world leader in medical tourism and has effectively leveraged Thailand’s many advantages in this sector. Unlike its competitors, it has focused on high-end tertiary care from a single campus. Narasimhan leads us through the history of the group, the secret to profit margins of 20%, the changing dynamics of medical tourism and the future of the Thai market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.